Brain Health accelerator aims to develop genetic therapies for brain disorders
The Allen Institute in Seattle has launched the Brain Health accelerator, a $400 million initiative to develop genetic therapies for brain disorders including Alzheimer’s, Parkinson’s, ALS, Lewy body dementia and Huntington’s. The effort is an outgrowth of the BRAIN Initiative, a public-private partnership announced by President Barack Obama in 2013. Ed Lein, who directs the institute’s brain health programs, said the latest genetic treatments allow scientists to control the activity of particular genes, opening the possibility for precision therapies. The accelerator has attracted researchers like Jeff Carroll, who carries the Huntington’s gene and previously studied the condition in mice at the University of Washington. Carroll said the scale of research needed is difficult with a small team, but the Allen Institute’s hundreds of staff allow a different approach. The institute was founded in 2003 by the late Paul Allen and his sister Jody Allen, and its policy of making databases publicly available means scientists worldwide can contribute to the research.
What’s reported
Key figures
Sources: NPR
